Business Wire

PROJECT44

12.2.2020 09:02:16 CET | Business Wire | Press release

Share
project44 Continues Global Expansion with Significant Growth in Europe

project44, the global leader in advanced visibility for shippers and logistics service providers, has experienced significant growth across Europe following several recent announcements, including opening an office in Paris , adding several new team members , and building partnerships with global technology leaders .

Since acquiring Europe’s leading visibility provider, GateHouse Logistics, in 2018, project44 has increased global growth reaching more than 300 enterprise customers with over 20% in Europe, including leading brands such as Amazon, Coop, and Yazaki.

“With an increased need for real-time data and visibility across the entire supply chain, shippers and logistics service providers need a single global provider,” said Michael Gross, Director IT, Supply Chain and Logistics at Yazaki. “We’re excited for project44’s network to grow in Europe and beyond. Their plans for expansion are critical for supporting our global supply chain.”

With coverage in about 50 countries, integrations with over 760 telematics providers, and partnerships with global technology leaders such as SAP, project44 enables customers to tap into the most extensive visibility network across North America and Europe. With European carrier onboarding available in 16 languages and applications in 14 languages, p44’s comprehensive support ensures customers see the ROI of visibility in the fastest way possible.

To accelerate this European growth, project44 opened a Paris office in December of 2019 and has since retained several key hires for continued European expansion, reaching over 80 European-based employees in Aalborg, Amsterdam, Frankfurt, and Milan.

New team members include Regional VP of Sales Mickael Devena , Value Engineering Director Jatin Garg , Head of European Marketing Lorenzo Stranges, and Strategic Account Director Marco Tarpi . Devena and Garg bring extensive experience in transportation visibility from their time at Shippeo, while Stranges and Tarpi come from global SaaS leaders, including DocuSign and IBM respectively.

Michel Stekelenburg will also join the team as the Strategic Account Director for the Benelux region. In addition to several roles in supply chain technology, Stekelenburg serves as the President of the Benelux Roundtable for the Council of Supply Chain Management Professionals (CSCMP).

To lead this growing team, project44 has promoted Executive Vice President of Operations, Jørgen B Nielsen, to General Manager of Europe. With more than 20 years of experience with technical challenges and project execution in IT and telecom, Jørgen led GateHouse Logistics through rapid growth as Chief Operating Officer.

“Building on the GateHouse Logistics’s decade of significant success and expertise, project44 has continued to expand the European visibility market, delivering a seamless product and experience for our global customers,” said Jørgen. “As supply chains increase logistics and transportation operations across geographies, project44 will continue to expand globally and provide the coverage our customers need to effectively run their businesses.”

With over $110 million USD in capital, project44 will continue to explore additional international growth to deliver a seamless transportation visibility offering for global supply chains. By partnering with leading global carriers, project44 has already started gaining coverage beyond North America and Europe in Turkey, Russia, Ukraine, and Belarus. The visibility provider will also begin extending tracking connections in Morocco.

About project44

project44 is the world’s leading advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations are able to increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Truckload, Rail, Intermodal, and Ocean. To learn more, visit www.project44.com .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release

New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p

Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release

By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c

Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release

Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S

European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release

Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye